Skip to main content
. 2019 Dec 16;2019(12):CD004290. doi: 10.1002/14651858.CD004290.pub3

2.9. Analysis.

2.9

Comparison 2 Target of rapamycin inhibitors (TOR‐I) versus calcineurin inhibitors (CNI): secondary outcomes, Outcome 9 Number with abnormal haematological values.